Bristol-Myers Squibb Co (BMY) Shares Sold by WestEnd Advisors LLC

Adjust Comment Print

The institutional investor owned 880,371 shares of the biopharmaceutical company's stock after selling 46,250 shares during the quarter. Kellogg Company (K) average trading volume of 3,094,355 during the past month is 13.1% above its average volume over the past year, indicating that investors have been more active than usual in the stock in recent times. Trading volume for Bristol-Myers Squibb Company was 6.59 Million in its previous trading session.

Bristol-Myers Squibb (NYSE:BMY) last issued its quarterly earnings results on Thursday, October 26th. It has underperformed by 39.89% the S&P500.

Cmt Asset Management Ltd decreased its stake in Petroleo Brasileiro Sa Petro (PBR) by 72.56% based on its latest 2017Q3 regulatory filing with the SEC. Pembroke Management Ltd bought 47,000 shares as the company's stock declined 1.69% while stock markets rallied. The institutional investor held 170,197 shares of the health care company at the end of 2017Q3, valued at $5.30M, down from 273,645 at the end of the previous reported quarter. Raub Brock Capital Management Lp bought 2,721 shares as the company's stock rose 6.75% with the market. The stock increased 0.55% or $0.355 during the last trading session, reaching $65.105. About 5.10M shares traded. It has outperformed by 22.86% the S&P500.

Glg Llc, which manages about $4.34 billion and $1.54B US Long portfolio, decreased its stake in Amgen Inc (NASDAQ:AMGN) by 3,643 shares to 39,178 shares, valued at $7.31 million in 2017Q3, according to the filing. It also reduced its holding in Finisar Corp (Prn) by 544,000 shares in the quarter, leaving it with 20.92M shares, and cut its stake in Synchrony Financial (NYSE:SYF).

'Extremely offensive': Africans outraged over 'racist' Trump remarks
The top Republican in the House, Speaker Paul Ryan of Wisconsin, called the president's "very unfortunate, unhelpful ". As an immigrant justice advocate, I of course want legal status for everyone trying to make it in this country.


Investors sentiment decreased to 1.22 in 2017 Q3. Its up 0.08, from 0.95 in 2017Q2. It worsened, as 60 investors sold SHW shares while 210 reduced holdings. Cap Services Of America reported 160,350 shares or 1.6% of all its holdings. Following the transaction, the executive vice president now owns 584,373 shares in the company, valued at approximately $37,031,717.01. Sigma Planning, a Michigan-based fund reported 34,854 shares. Td Asset Management owns 0% invested in Valmont Industries, Inc. Longbow downgraded the shares of SHW in report on Wednesday, September 23 to "Neutral" rating. Steinberg Global Asset Management owns 15,491 shares for 0.15% of their portfolio. Wesbanco Financial Bank stated it has 490,377 shares or 1.63% of all its holdings. 5,865 were accumulated by United National Bank & Trust. (NYSE:AIN). Invesco Limited invested in 904,990 shares or 0.02% of the stock. Wealthtrust Fairport Ltd Liability Corp holds 0.04% or 6,377 shares in its portfolio.

Praxair, Inc. (PX) pulled off a 0.73 percent gain and now trades for $163.81. Connecticut-based Hartford Invest Mgmt has invested 0.04% in A. O. Smith Corporation (NYSE:AOS). Lord Abbett & Ltd Company, a New Jersey-based fund reported 593,682 shares. Employees Retirement System Of Ohio owns 35,198 shares. Nwq Investment Mngmt Com Limited Com has invested 1% in Albany International Corp. (TSE:BOS) has 0.00% since January 11, 2017 and is. Therefore 33% are positive. Orion Engineered Carbons had 19 analyst reports since August 10, 2015 according to SRatingsIntel. The company was maintained on Wednesday, September 13 by Canaccord Genuity. The stock of J&J Snack Foods Corp. The firm has "Buy" rating given on Monday, December 19 by Jefferies. Firm's net income measured an average growth rate of 4.20%. They expect $-0.33 EPS, down 126.61% or $1.57 from last year's $1.24 per share. A company with higher PE ratio is more worthy against a company with lower PE ratio. Legal And General Grp Inc Public Limited owns 0.41% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 8.62 million shares.

Following some medium-term indicators on shares of Bristol-Myers Squibb Company (BMY), we can see that the 40-day commodity channel index signal is presently Hold while the 50-day Parabolic SAR generates a Buy signal. Therefore 32% are positive. Sherwin-Williams Company had 57 analyst reports since July 22, 2015 according to SRatingsIntel. Jefferies maintained the shares of BMY in report on Thursday, November 16 with "Hold" rating. The firm has "Underweight" rating given on Monday, August 24 by Piper Jaffray. Barclays Capital maintained the stock with "Equal-Weight" rating in Tuesday, November 7 report. The company was maintained on Monday, July 10 by Cowen & Co. The firm has "Buy" rating by Citigroup given on Tuesday, October 6. The rating was maintained by Credit Suisse with "Outperform" on Monday, May 9. Gfs Advsrs Ltd Liability Co has 0.07% invested in Bristol-Myers Squibb Company (NYSE:BMY). The firm earned "Neutral" rating on Thursday, January 5 by Longbow. Morgan Stanley has 14.09 million shares for 0.27% of their portfolio. It also increased its holding in Matador Res Co (NYSE:MTDR) by 41,130 shares in the quarter, for a total of 121,765 shares, and has risen its stake in Sei Investments Co (NASDAQ:SEIC). Lynch Thomas J. Jr. sold $335,172 worth of Bristol-Myers Squibb Company (NYSE:BMY) on Tuesday, December 12. Shares for $560,400 were sold by Caldarella Joseph C.

Investors sentiment increased to 1.03 in Q3 2017. Its down 0.16, from 1.18 in 2017Q2. Sold All: 62 Reduced: 519 Increased: 460 New Position: 137. Rampart Investment Management Limited Liability reported 0.49% stake. Knott David M accumulated 2,225 shares. Manning Napier Advsr Ltd Liability has invested 1.03% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Howland Management Limited invested in 42,702 shares. 51,023 were accumulated by Boulegeris Invests Incorporated. Private Advisor Ltd Company holds 0.37% or 231,285 shares. Ashford Cap Management Inc holds 0.07% or 6,596 shares. SunTrust Banks upgraded shares of Bristol-Myers Squibb from a "hold" rating to a "buy" rating in a research report on Monday, October 30th.

Comments